• Login
NORVANREPORTS.COM |  Business News, Insurance, Taxation, Oil & Gas, Maritime News, Ghana, Africa, World
  • Home
  • News
    • General
    • Political
  • Economy
  • Business
    • Agribusiness
    • Aviation
    • Banking & Finance
    • Energy
    • Insurance
    • Manufacturing
    • Markets
    • Maritime
    • Real Estate
    • Tourism
    • Transport
  • Technology
    • Telecom
    • Cyber-security
    • Cryptocurrency
    • Tech-guide
    • Social Media
  • Features
    • Interviews
    • Opinions
  • Reports
    • Banking/Finance
    • Insurance
    • Budgets
    • GDP
    • Inflation
    • Central Bank
    • Sec/Gse
  • Lifestyle
    • Sports
    • Entertainment
    • Travel
    • Environment
    • Weather
  • NRTV
    • Audio
    • Video
No Result
View All Result
No Result
View All Result
NORVANREPORTS.COM |  Business News, Insurance, Taxation, Oil & Gas, Maritime News, Ghana, Africa, World
No Result
View All Result
Home highlights

Nigeria seeks 30 million doses of J&J vaccine from African Union

6 years ago
in highlights, Home, home-news, latest News
1 min read
0 0
0
54
VIEWS
Share on FacebookShare on TwitterShare on Linkedin

RelatedPosts

Three Airport Projects, One Unanswered Question: Who Will Fly the Routes?

The AI Race Is Entering a New Phase: Who Pays, And Who Can Repay?

Redalpine Closes Largest Early-Stage Fund at $250m as Investors Back European Deep Tech

Nigeria plans to get 29.6 million doses of Johnson and Johnson vaccine through the African Vaccine Acquisition Trust led by Afreximbank, the finance ministry said.

The government is working on a supplementary budget to cover vaccine procurement and delivery, Finance Minister Zainab Ahmed said in a statement on Friday. Already, 29 billion naira has been released for the deployment of vaccines, which is 52% of what is required from 2021 to 2022, she said.

Africa’s most populous country of about 200 million people has set a target of vaccinating 70% of its citizens who are 18 years and above between this year and next, Ahmed said. The vaccine commitment through the COVAX initiative would cover 43.1 million of the country’s population.

Nigeria received about 4 million doses of a vaccine developed by AstraZeneca Plc and the University of Oxford in March with about 1.3 million people getting their first doses as of March 6.

Source: bloomberg
Via: norvanreports
Tags: AfreximbankCOVAX initiativeJohnson and Johnson vaccineNigeria
No Result
View All Result

Who we are?

NORVANREPORTS.COM |  Business News, Insurance, Taxation, Oil & Gas, Maritime News, Ghana, Africa, World

NorvanReports is a unique data, business, and financial portal aimed at providing accurate, impartial reporting of business news on Ghana, Africa, and around the world from a truly independent reporting and analysis point of view.

© 2020 Norvanreports – credible news platform.
L: Hse #4 3rd Okle Link, Baatsonaa – Accra-Ghana T:+233-(0)26 451 1013 E: news@norvanreports.com info@norvanreports.com
All rights reserved we display professionalism at all stages of publications

No Result
View All Result
  • Home
  • Business
    • Agribusiness
    • Aviation
    • Energy
    • Insurance
    • Manufacturing
    • Real Estate
    • Maritime
    • Tourism
    • Transport
    • Banking & Finance
    • Trade
    • Markets
  • Economy
  • Reports
  • Technology
    • Cryptocurrency
    • Cyber-security
    • Social Media
    • Tech-guide
    • Telecom
  • Features
    • Interviews
    • Opinions
  • Lifestyle
    • Entertainment
    • Sports
    • Travel
    • Environment
    • Weather
  • NRTV
    • Audio
    • Video

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
NORVANREPORTS.COM | Business News, Insurance, Taxation, Oil & Gas, Maritime News, Ghana, Africa, World
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.